Author Archives: Lisa Newey-Keane

Lisa is Malvern Instruments' Life Science Sector Marketing Manager. She holds a PhD in microbiology and protein biochemistry from the University of Birmingham. Lisa then moved to the product characterization team at Lonza Biologics in Slough and specialized in the use of HPLC and mass spectrometry for the analysis of therapeutic antibodies, later transferring these skills to her work at Shimadzu . Lisa has also worked within bioanalysis both at Novozymes in Nottingham and most recently at Quotient Bioresearch in Cambridgeshire, where she specialized in antimicrobial drug development. Lisa joined Malvern Instruments as the Biopharmaceutical Product Manager, before moving to the Biopharmaceutical Portfolio Manager role. She is now responsible for Malvern's marketing within both small molecule and also biological drug development and manufacture, on a global basis.

Published 3 Mar 2020

Webinar – Focus on Pharma: Assessing in vitro bioequivalence: Oral Solid Dose formulations

Oral Solid Dose Drug Products Oral solid dose (OSD) drug products represent the largest class of products sold by the pharmaceutical industry, accounting for over 60% of global pharmaceutical sales. As a result, they represent a significant opportunity for generic…READ MORE >

Published 31 Jan 2019

John Carpenter’s keynote speech at next month’s Biophysical & Particle Characterization Symposium

On 19th February, Professor John F. Carpenter will be delivering his keynote presentation, entitled: ‘Aggregates and particles in therapeutic protein products: Causes, characterization and control’ at Malvern Panalytical’s Symposium on Biophysical and Particle Characterization in Cambridge, UK. John is Professor…READ MORE >

Tags: , ,

Published 8 Jan 2019

Don’t miss your chance to meet protein and particle experts!

The New Year brings a unique opportunity for interaction with key opinion leaders at Malvern Panalytical’s free-to-attend Symposium on Biophysical and Particle Characterization, taking place at Medimmune Cambridge, UK, on February 19th. Please take a look at the event page…READ MORE >

Tags: ,

Published 1 Jun 2017

Customer Spotlight: Collaborating for safer biopharmaceuticals

Our key driver at Malvern Instruments is to create technologies that make a difference or solve a problem, and working hand-in-hand with our customers enables us to make sure that’s exactly what’s happening, out in the field.  We place a high value on…READ MORE >

Published 2 Feb 2017

Malvern Instruments Gold Sponsors of Biosimilars & Biologics Congress 2017

We are proud to announce Malvern Instruments’s Gold Sponsorship of Global Engage’s Biosimilars and Biologics Congress 2017.  This two-day event will be taking place on Monday 6th and Tuesday 7th March 2017, at the Leonardo Royal Hotel Berlin Alexanderplatz. This…READ MORE >